The serendipitous discovery that inhibiting type 5 phosphodiesterase (PDE5) using sildenafil, a potent PDE5 inhibitor (PDE5i) initially developed for cardioprotection, introduced the possibility of ...

The difference today is that he is doing it via Zoom from a corner office at Gap Inc.’s corporate mother ship in San Francisco. And there is some question about whether the gown, made of Gap’s ...

Ifinatamab deruxtecan is under clinical development by Daiichi Sankyo and currently in Phase II for Gastroesophageal (GE) Junction Carcinomas ... monoclonal antibody attached to a topoisomerase I ...

The Dorsetshire Gap, the target of this walk, is a junction of ancient trackways at a natural break in the high ridge between Nordon Hill and Nettlecombe Tout. The same routes still converge at ...

Travelling through one of London’s most notorious junctions could soon be different if plans to shake it up go ahead. The ‘Shoreditch Triangle’ area in east London was named the capital’s ...

These next-generation STAT6 inhibitors demonstrate excellent oral bioavailability, cell permeability, and metabolic stability, and do not target STAT6 for degradation. DeepCure expects to select a ...